Anand Kayakalp Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.19 M
- Company Age 26 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 13.23%
- Profit Growth -50.12%
- Ebitda 7.02%
- Net Worth 7.01%
- Total Assets 10.49%
About Anand Kayakalp Pharmacy
Anand Kayakalp Pharmacy Private Limited. (AKPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 August 1998 and has a history of 26 years and six months. Its registered office is in New Delhi, Delhi.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.19 M, as per Ministry of Corporate Affairs (MCA) records.
Pramila Mishra and Ankur Mishra serve as directors at the Company.
Company Details
- Location New Delhi, Delhi
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24233DL1998PTC095617
- Company No.
095617
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Aug 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Anand Kayakalp Pharmacy Private Limited. offer?
Anand Kayakalp Pharmacy Private Limited. offers a wide range of products and services, including Diabetic Herbal Medicine, Diabetic Herbal Tablets & Capsules, Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Ayurvedic Tablets, Cosmetics, Hair & Beauty Products, Hair Care Products.
Who are the key members and board of directors at Anand Kayakalp Pharmacy?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramila Mishra  | Director | 18-Aug-1998 | Current |
| Ankur Mishra | Additional Director | 16-Mar-2024 | Current |
Financial Performance of Anand Kayakalp Pharmacy.
Anand Kayakalp Pharmacy Private Limited., for the financial year ended 2020, experienced significant growth in revenue, with a 13.23% increase. The company also saw a substantial fall in profitability, with a 50.12% decrease in profit. The company's net worth moved up by a moderate rise of 7.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anand Kayakalp Pharmacy?
In 2020, Anand Kayakalp Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anand Kayakalp Pharmacy?
Unlock and access historical data on people associated with Anand Kayakalp Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anand Kayakalp Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anand Kayakalp Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
